Epistaxis
Clinical trials for Epistaxis explained in plain language.
Never miss a new study
Get alerted when new Epistaxis trials appear
Sign up with your email to follow new studies for Epistaxis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New ointment could tame HHT nosebleeds
Symptom relief Not yet recruitingThis early-phase trial tests a new nasal ointment called TOR-582, which contains sirolimus, in 27 adults with hereditary hemorrhagic telangiectasia (HHT) who have frequent nosebleeds. Participants apply the ointment inside their nostrils twice daily for 12 weeks, with different s…
Matched conditions: EPISTAXIS
Phase 1 • Sponsor: Columbia University • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
Nosebleed breakthrough? gel vs. jelly in new study
Symptom relief Not yet recruitingThis study compares two gels—hyaluronic acid gel and petroleum jelly—to see which works better for stopping nosebleeds. About 50 people with nosebleeds that start in the front of the nose will be treated with one of the gels. The main goal is to see which gel stops bleeding faste…
Matched conditions: EPISTAXIS
Sponsor: Assiut University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Can a plant gel beat vaseline for nosebleeds?
Symptom relief Not yet recruitingThis study compares a plant-based gel (B-sitosterol) to plain Vaseline for treating frequent, unexplained nosebleeds. About 162 people who have had at least two nosebleeds in the past month will apply one of the two gels inside their nose for a period. The goal is to see which on…
Matched conditions: EPISTAXIS
Phase 4 • Sponsor: Assiut University • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC